References
- Bargar E. M., Walle U. K., Bai S. A., Walle T. Quantitative metabolic fate of propranolol in the dog, rat and hamster using radiotracer, high performance liquid chroma‐tography, and gas chromatography‐mass spectrometry techniques. Drug Metabolism and Disposition 1983; 11: 266–272
- Bates D. J., Foster A. B., Griggs L. J., Jarman M., Leclercq G., Devleeschouwer N. Metabolism of tamoxifen by isolated rat hepatocytes: anti‐estrogenic activity of tamoxifen N‐oxide. Biochemical Pharmacology 1982; 31: 2823–2827
- Baur H., Kasperek S., Pfaff E. Criteria of viability of isolated liver cells. Hoppe‐Seylers Zeitschrift fur Physiologische Chemie 1975; 356: 827–838
- Berry M. N., Friend D. S. High‐yield preparation of isolated rat liver parenchymal cells. Journal of Cell Biology 1969; 43: 506–520
- Billings R. E., McMahon R. E., Ashmore J., Wagler S. R. The metabolism of drugs in isolated rat hepatocytes. Drug Metabolism and Disposition 1977; 5: 518–525
- Bond P. A. Metabolism of propranolol (Inderal), a potent specific β‐adrenergic receptor blocking agent. Nature 1967; 213: 721–722
- Bourne G. R. The metabolism of β‐adrenoreceptor blocking drugs. Progress in Drug Metabolism, J. W. Bridges, L. F. Chausseaud. Wiley, New York 1981; Vol 6: 78–102
- Ch'ih J. J., Lin T., Devlin J. M. Activation and deactivation of aflatoxin B1, in isolated rat hepatocytes. Biochemical and Biophysical Research Communication 1983; 110: 668–674
- Evans G. H., Shand D. G. Disposition of propranolol. Clinical Pharmacology and Therapeutics 1973; 14: 494–500
- Fry J. R., Jones C. A., Wiebkin P., Belleman P., Bridges J. W. The enzymic isolation of adult rat hepatocytes in a functional and viable state. Analytical Biochemistry 1976; 71: 341–350
- Howard R. B., Christensen A. K., Gibbs F. A., Pesch L. A. The enzymatic preparation of isolated intact parenchymal cells from rat liver. Journal of Cell Biology 1967; 35: 675–684
- Keppler D. O. R., Schulz‐Hostege C., Fauler J., Reiffen K. A., Schneider F. Uridylate trapping, induction of UTP deficiency, and stimulation of pyrimidine synthesis de novo by D‐galactosone. Biochemical Journal 1982; 206: 139–146
- Keppler D. O. R., Rudigier J. F., Bischoff E., Decker K. F. A. The trapping of uridine phosphates by D‐galactosamine, D‐glucosamine and 2‐deoxy‐D‐galactose. European Journal of Biochemistry 1970; 17: 246–253
- Koike M., Sugeno K., Hirata M. Sulphoconjugation and glucuronidation of salicylamide in isolated rate hepatocytes. Journal of Pharmaceutical Sciences 1981; 70: 308–311
- Koster H., Halsema I., Scholtens E., Knippers M., Mulder G. J. Dose‐dependent shifts in the sulphation and glucuronidation of phenolic compounds in the rat in vivo and in isolated hepatocytes. Biochemical Pharmacology 1981; 30: 2569–2575
- Marten T. R., Bourne G. R., Miles G. S., Shuker B., Rankine H. D., Dutka V. N. The metabolism of ICI 118,587, a partial agonist of B1,‐adrenoceptors, in mice, rats, rabbits, dogs and humans. Drug Metabolism and Disposition 1984; 12: 652–660
- Moldeus P., Andersson B., Gergely V. Regulation of glucuronidation and sulphate conjugation in isolated hepatocytes. Drug Metabolism and Disposition 1979; 7: 416–419
- Mulder G. J., Scholtens E. The availability of inorganic sulphate in blood for sulphate conjugation of drugs in rat liver, in vivo. Biochemical Journal 1978; 172: 247–251
- Ong H., Du Souich P., Marchand C. In vivo study of propranolol and metabolite(s) disposition in rat liver. Drug Metabolism and Disposition 1981; 9: 529–534
- Peterson J. W., Connolly M. E., Dollery C. T., Hayes A., Cooper R. G. The pharmacodynamics and metabolism of propranolol in man. Pharmacologica Clinica 1970; 2: 127–133
- Shand D. G., Nickolls E. M., Oates J. A. Plasma propranolol levels in adults. Clinical Pharmacology and Therapeutics 1970; 11: 112–120
- Sundheimer D. W., Brendel K. Factors influencing sulphation in isolated rat hepatocytes. Life Sciences 1983; 34: 23–29
- Tindell G. L., Walle T., Gaffney T. E. Rat liver microsomal metabolism of propranolol: identification of seven metabolites by gas chromatography‐mass spectrometry. Life Sciences 1972; 11: 1029–1036
- Ullrich D., Bock K. W. Inhibition of glucuronide formation by D‐galactosome or D‐galactosamine in isolated hepatocytes. Biochemical Pharmacology 1984; 33: 1827–1830